Apply for Funding
標的研究プログラム
Past RFP
RFP Target Research Platform 2018-001
The GHIT Fund announces an investment opportunity for the Target Research Platform (TRP) in Partnership with the Wellcome Trust. The TRP investments are intentionally broad in potential scope and focus on new technologies and novel approaches.
TRP investments are intentionally broad in potential scope and focus on new technologies and novel approaches. Proposals must be within the project scope and investment eligibility below in order to be considered. The TRP is currently focused on technologies and approaches that address unmet or priority needs within malaria, tuberculosis, HIV/AIDS and Neglected Tropical Diseases listed in the GHIT Intent to Apply form.
Proposed projects should be primarily originated from and be led by Japanese organizations and partnerships will need to be between eligible Japanese and non-Japanese organizations.
Interested applicants can find detailed information on the RFP and the Intent to Apply form below.
RFP and Intent to Apply
Key RFP Milestone Dates
RFP Release June 20, 2018
Intent to Apply No later than 10:00 am Tokyo time on July 20, 2018
Submit via Editorial Manager® for Target Research Platform
(http://www.editorialmanager.com/ghitfund_trp/)
Q&A No later than 10:00 am Tokyo time on August 13, 2018
Submit questions to TRPResponse@ghitfund.org
Email Subject Line: GHIT-RFP-TRP-2018-001_Questions
Full Proposal Due No later than 10:00 am Tokyo time on August 17, 2018
Submit via Editorial Manager® for Target Research Platform
Proposals Evaluation and Interview Processes August 2018 – February 2019
Award Notification to All Applicants February 2019
Investment Agreement Fully Executed (Awarded Proposals) March 2019
GHIT Fund RFP Target Research Platform in Partnership with Wellcome Trust 2017-002
The GHIT Fund announces an investment opportunity for the Target Research Platform (TRP) in Partnership with the Wellcome Trust. The TRP investments are intentionally broad in potential scope and focus on new technologies and novel approaches.
TRP investments are intentionally broad in potential scope and focus on new technologies and novel approaches. Proposals must be within the project scope and investment eligibility below in order to be considered. The TRP is currently focused on technologies and approaches that address unmet or priority needs within malaria, tuberculosis, HIV/AIDS and Neglected Tropical Diseases listed in the GHIT Intent to Apply form.
Proposed projects should be primarily originated from and be led by Japanese organizations and partnerships will need to be between eligible Japanese and non-Japanese organizations.
Interested applicants can find detailed information on the RFP and the Intent to Apply form below.
RFP and Intent to Apply
Key RFP Milestone Dates
RFP Release July 25, 2017
Intent to Apply No later than 10:00 am Tokyo time on August 21, 2017
Submit via Editorial Manager® for Target Research Platform
Q&A No later than 10:00 am Tokyo time on August 17, 2017
Submit questions to TRPResponse@ghitfund.org
Email Subject Line: GHIT-RFP-TRP-2017-002_Questions
Full Proposal Due No later than 10:00 am Tokyo time on September 19, 2017
Submit via Editorial Manager® for Target Research Platform
Proposals Evaluation and Interview Processes September 2017 – February 2018
Award Notification to All Applicants February 2018
Investment Agreement Fully Executed (Awarded Proposals) March 2018
GHIT Fund RFP Target Research Platform in Partnership with Wellcome Trust 2017-001
The GHIT Fund announces an investment opportunity for the Target Research Platform (TRP) in Partnership with the Wellcome Trust.
The TRP investments are intentionally broad in potential scope and focus on new technologies and novel approaches. Proposals should be innovative in nature and focused on early-stage discovery and technologies and approaches that address unmet or priority needs within malaria, tuberculosis, HIV/AIDS and any of the 17 Neglected Tropical Diseases recognized by the World Health Organization (http://www.who.int/neglected_diseases/diseases/summary/en/).
Proposed projects should be primarily originated from and be led by Japanese organizations and partnerships will need to be between eligible Japanese and non-Japanese organizations.
Interested applicants can find detailed information on the RFP and the Intent to Apply form below.
RFP and Intent to Apply
Key RFP Milestone Dates
RFP Release October 7, 2016
Intent to Apply No later than 10:00 am Tokyo time on November 10, 2016
Submit via Editorial Manager® for Target Research
Q&A No later than 10:00 am Tokyo time on December 26, 2016
Submit questions to TRPResponse@ghitfund.org
Email Subject Line: GHIT Fund-RFP-TRP-2017-001_Questions
Full Proposal Due No later than 10:00 am Tokyo time on January 13, 2017
Submit via Editorial Manager® for Target Research
Proposals Evaluation and Interview Processes January 2017 - July 2017
Award Notification to All Applicants End of July 2017
Investment Agreement Fully Executed (Awarded Proposals) Mid-September 2017
GHIT Fund RFP Target Research Platform in Partnership with Grand Challenges 2016-002
The GHIT Fund announces an investment opportunity for the Target Research Platform in Partnership with Grand Challenges (TRP).
The TRP investments are intentionally broad in potential scope and focus on new technologies and novel approaches. Proposals should be innovative in nature and focused on early-stage discovery and technologies and approaches that address unmet or priority needs within Buruli ulcer, Chagas disease, Crystosporidium, leishmaniasis, lymphatic filariasis, malaria, mycetoma (non pathogen-specific solution), schistosomiasis, and tuberculosis.
Proposed projects should be primarily originated from and be led by Japanese organizations and partnerships will need to be between eligible Japanese and non-Japanese organizations.
Interested applicants can find detailed information on the RFP and the Intent to Apply form below.
RFP and Intent to Apply
Key RFP Milestone Dates
RFP Release August 22, 2016
Intent to Apply No later than 10:00 am Tokyo time on September 14, 2016
Submit via Editorial Manager® for Target Research Platform
Q&A No later than 10:00 am Tokyo time on October 7, 2016
Submit questions to TRPResponse@ghitfund.org
Email Subject Line: GHIT Fund-RFP-TRP-2016-002_Questions
Full Proposal Due No later than 10:00 am Tokyo time on October 11, 2016
Submit via Editorial Manager® for Target Research Platform
Proposals Evaluation and Interview Processes September 2016 - February 2017
Award Notification to All Applicants No later than February 10, 2017
Investment Agreement Fully Executed (Awarded Proposals) No later than March 31, 2017
GHIT Fund RFP Target Research Platform in Partnership with Grand Challenges 2016-001
The GHIT Fund endeavors to facilitate collaboration and funding of global health technology R&D, to build momentum, and to demonstrate action and results. The Target Research Platform in Partnership with Grand Challenges (TRP) is one of three platforms within the GHIT Fund’s Discovery Investment focus area and is the GHIT Fund’s newest platform.
These investments are intentionally broad in potential scope and focus on new technologies and novel approaches. The TRP is currently focused on technologies and approaches that address unmet or priority needs within malaria, tuberculosis, Chagas disease, and leishmaniasis.
To know more about the details, please see the RFP.
RFP and Intent to Apply
Key RFP Milestone Dates
RFP Release October 1, 2015
Intent to Apply Deadline extended to 10:00 am Tokyo time on November 30, 2015
Submit via Editorial Manager® for Target Research Platform
(http://www.editorialmanager.
com/ghitfund_trp/) Q&A No later than 10:00 am Tokyo time on February 10, 2016
Submit questions to TRPResponse@ghitfund.org
Email Subject Line: GHIT Fund-RFP-TRP-2016-001_Questions
Full Proposal Due No later than 10:00 am Tokyo time on February 17, 2016
Submit via Editorial Manager® for Target Research Platform
Award Notification to All Applicants No later than August 1, 2016
GHIT Fund RFP Target Research Platform in Partnership with Grand Challenges 2015-001
The GHIT Fund endeavors to facilitate collaboration and funding of global health technology R&D, to build momentum, and to demonstrate action and results. The Target Research Platform in Partnership with Grand Challenges (TRP) is one of three platforms within the GHIT Fund’s Discovery Investment focus area and is the GHIT Fund’s newest platform.
These investments are intentionally broad in potential scope and focus on new technologies and novel approaches. The TRP is currently focused on technologies and approaches that address unmet or priority needs within malaria, tuberculosis, Chagas disease, and leishmaniasis.
To know more about the details, please see the RFP.
RFP and Intent to Apply
Key RFP Milestone Dates
RFP Release February 5, 2015
Intent to Apply No later than 10:00 am Tokyo time on March 13, 2015
Submit via GHIT Fund online document submission system
Q&A No later than 10:00 am Tokyo time on March 30, 2015Submit questions to TRPResponse@ghitfund.orgEmail Subject Line: GHIT Fund-RFP-TRP-2015-001_Questions Full Proposal Due No later than 10:00 am Tokyo time on April 3, 2015 Submit via GHIT Fund online document submission system
Award Notification to All Applicants No later than August 1, 2015
製品開発投資のプロセス
申請者
Intent to Apply Formの提出
公募案件(RFP)へ申請を希望する機関は、RFPの応募期間内に、Editorial Manager® (オンラインシステム)からIntent to Apply (ITA) Form の提出が必須となります。上記の方法で提出がなされなかったITA Formまたはプロポーザル (申請書)は、受け付けることはできません。ITA Formは、公募案件の内容が決定次第、GHIT Fundのウェブサイトにおいて公表されます。
※Intent to Apply (ITA)とは、プロポーザルを提出する前の段階で、GHIT Fundの公募案件に対して申請する意志をGHIT Fundに伝えることを指します。ITAの審査は、各RFP毎に個別かつ単独で行われているため、複数回応募、あるいは提出後の取り消しが以後のRFPにおける審査に影響を及ぼすことはありません。
GHIT Fundマネジメントチーム
事前審査
ITA Formを提出した申請者には、受理確認のメールが送られます。GHIT Fundマネジメントチームは、提出されたITA Formの内容が申請要件の研究対象に沿ったものであるかを確認し、申請内容が申請要件に沿っていない場合は、申請プロジェクトの内容が審査対象外であることを申請者に伝えます。指定された提出期限までに問題点を改善した場合には、ITA Formの再提出が可能です。
選考委員会
事前審査
ITA Formの提出後、GHIT Fund の選考委員会による事前審査が行われ（RFPによって変更あり）、審査を通過した申請者のみに、GHIT Fund からプロポーザル、予算、タイムラインを記入するテンプレート一式がEメールにて送付されます。
申請者
プロポーザルの提出
申請者は必要事項を記入し、定められた期限までにEditorial Manager®からプロポーザルを提出することが求められます。一度提出されたプロポーザルは、修正することはできません。プロポーザル提出後は以下のような基準に基づいてGHIT Fundマネジメントチームが事前審査を行います。Proposalの審査は、各RFP毎に個別かつ単独で行われているため、複数回応募、あるいは提出後の取り消しが以後のRFPにおける審査に影響を及ぼすことはありません。
- パートナーシップは、GHIT Fundの資格基準を満たしているか
- プロジェクトの目的は、RFPに明記された研究対象の範囲に沿ったものであるか
- プロポーザル一式がすべて揃い、書類に不備がないか
外部審査員
プロポーザルの評価
事前審査を通過したプロポーザルは、少なくとも３名の外部審査員によって評価が行われます。外部審査員とは、グローバルヘルスR&Dに精通し、客観的な基準に基づきプロポーザルを評価することができる専門家で、申請者との個人的、専門的、金銭的関係がないことを事前に書面で宣言することが求められます。外部審査員は、以下のような基準に基づいてプロポーザルを評価します。
- 科学的、および技術的価値（Scientific and technical merit）
- 生み出されるインパクト（Potential impact）
- パートナーシップとプロジェクトマネジメント（Partnership and project management）
選考委員会
インタビューの実施と投資案件の推薦
外部審査員による評価の集計結果とGHIT Fundの選考委員会の評価に基づき、各案件は評価スコアによって順位付けされます。その中から、上位の申請者が選考委員とのインタビューに招待されます。選考委員会はプロポーザルと製品開発の計画を評価の上、理事会に対して推薦する投資案件を選定します。
GHIT Fundマネジメントチーム&製品開発パートナー
審査結果通知・契約締結・投資
理事会での承認後、GHIT Fundマネジメントチームからすべての申請者に対して、メールにて選考結果を通知します。採択された案件の申請者は、採択通知が届いてから1ヶ月以内に、全製品開発パートナー署名済みのGHIT Fundとの契約書、並びに、各パートナーの役割と責任が明確に定義されたパートナー間の共同研究契約書をGHIT Fundに提出する必要があります。これらの条件が満たされない場合には契約が無効になる可能性がありますのでご注意ください。申請者は、製品開発パートナーの中から、代表機関（投資受領機関）を選択する必要があります。代表機関はプロジェクトの成果に対する責任を負い、代表機関における責任者は連絡窓口として、GHIT Fundとのコミュニケーションを行います。
GHIT Fundマネジメントチーム
モニタリングと評価の開始
契約を締結しプロジェクトが開始すると、GHITマネジメントチームはモニタリングと評価を開始します。プロジェクトに関するデータと情報がシステム上で管理されます。
GHIT Fundマネジメントチーム&製品開発パートナー
モニタリングと評価
投資案件の進捗状況を把握するため、GHIT Fundは年に2回、全ての投資案件の進捗確認を実施します。これにより、各案件におけるマイルストーンの達成度を確認し、投資の継続、変更、または終了の決定を行います。このモニタリングと評価を通じて、製品開発パートナーはウェブサイト上のシステムを用いて進捗報告を提出し、その報告をもとに、GHIT Fundマネジメントチームとの会議を行います。